Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)
600566.SS on Shanghai Stock Exchange
31.52CNY
19 Jul 2019
31.52CNY
19 Jul 2019
Change (% chg)
¥-0.11 (-0.35%)
¥-0.11 (-0.35%)
Prev Close
¥31.63
¥31.63
Open
¥31.63
¥31.63
Day's High
¥32.20
¥32.20
Day's Low
¥31.30
¥31.30
Volume
4,331,695
4,331,695
Avg. Vol
6,677,540
6,677,540
52-wk High
¥51.49
¥51.49
52-wk Low
¥27.61
¥27.61
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 2,079.42 | 0.626 |
| FY 2018 | Dec '18 | 1,664.22 | 0.465 |
| Sep '18 | 1,740.26 | 0.570 | |
| Jun '18 | 1,676.12 | 0.464 | |
| Mar '18 | 2,127.61 | 0.574 | |
| FY 2017 | Dec '17 | 1,428.39 | 0.390 |
| Sep '17 | 1,403.45 | 0.402 | |
| Jun '17 | 1,405.36 | 0.360 | |
| Mar '17 | 1,404.81 | 0.359 |
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-19 | 4 | 8,632.68 | 8,724.00 | 8,491.73 | 8,691.12 |
| Year Ending Dec-20 | 5 | 10,255.40 | 10,600.00 | 9,918.00 | 10,329.90 |
| Earnings (per share) | |||||
| Year Ending Dec-19 | 4 | 2.52 | 2.60 | 2.46 | 2.49 |
| Year Ending Dec-20 | 5 | 3.12 | 3.24 | 3.00 | 3.16 |
Sales and Profit Figures in China Yuan Renminbi (CNY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 14.83 | 30.29 | 34.03 | |
| P/E High - Last 5 Yrs. | 31.48 | 47.71 | 54.30 | |
| P/E Low - Last 5 Yrs. | 16.19 | 27.44 | 28.31 | |
| Beta | 0.51 | 1.00 | 0.99 | |
| Price to Sales (TTM) | 3.59 | 6.06 | 7.86 | |
| Price to Book (MRQ) | 4.30 | 3.90 | 4.40 | |
| Price to Tangible Book (MRQ) | 4.68 | 4.20 | 5.12 | |
| Price to Cash Flow (TTM) | -- | 22.26 | 24.07 | |
| % Owned Institutions | -- | 0.79 | 1.79 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 3.90 | 1.81 | 1.65 | |
| Dividend Yield - 5 Year Avg | 2.70 | 1.48 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 6.75 | 6.83 | |
| Payout Ratio(TTM) | 57.90 | 51.32 | 47.33 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -2.26 | 12.80 | 14.77 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 12.49 | 6.34 | 8.25 | |
| Sales - 5 Yr. Growth Rate | 24.11 | 8.41 | 9.49 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 9.07 | 16.76 | 18.04 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 23.12 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 25.73 | 5.63 | 7.06 | |
| Capital Spending - 5 Yr. Growth Rate | 19.86 | 6.91 | 7.87 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.48 | 2.53 | 2.53 |
| Current Ratio (MRQ) | 2.64 | 3.58 | 3.54 |
| LT Debt to Equity (MRQ) | 9.31 | 11.64 | 12.62 |
| Total Debt to Equity (MRQ) | 9.31 | 16.18 | 17.68 |
| Interest Coverage (TTM) | -- | 7.34 | 14.66 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 83.25 | 51.24 | 50.17 | |
| Gross Margin - 5 Yr. Avg. | 84.67 | 50.51 | 51.32 | |
| EBITD Margin (TTM) | 26.75 | -- | -- | |
| EBITD - 5 Yr. Avg | 25.48 | 17.64 | 16.43 | |
| Operating Margin (TTM) | 26.99 | -2.04 | -6.76 | |
| Operating Margin - 5 Yr. Avg. | 23.53 | 13.98 | 11.93 | |
| Pre-Tax Margin (TTM) | 28.38 | -2.38 | -7.12 | |
| Pre-Tax Margin - 5 Yr. Avg. | 24.32 | 18.89 | 15.92 | |
| Net Profit Margin (TTM) | 24.18 | -6.07 | -10.91 | |
| Net Profit Margin - 5 Yr. Avg. | 20.79 | 14.20 | 11.29 | |
| Effective Tax Rate (TTM) | 14.80 | 20.25 | 20.57 | |
| Effective Tax Rate - 5 Yr. Avg. | 14.49 | 22.93 | 24.48 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 1,002,102 | 1,021,459,648 | 881,592,518 | |
| Net Income/Employee (TTM) | 242,296 | 119,510,762 | 103,165,677 | |
| Receivable Turnover (TTM) | 3.30 | 5.64 | 5.90 | |
| Inventory Turnover (TTM) | 4.84 | 2.60 | 3.63 | |
| Asset Turnover (TTM) | 0.89 | 0.89 | 0.85 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 21.63 | 10.56 | 10.25 | |
| Return on Assets - 5 Yr. Avg. | 21.48 | 11.74 | 11.22 | |
| Return on Investment (TTM) | 28.15 | 13.03 | 12.70 | |
| Return on Investment - 5 Yr. Avg. | 28.73 | 14.86 | 14.21 | |
| Return on Equity (TTM) | 31.94 | 14.20 | 17.29 | |
| Return on Equity - 5 Yr. Avg. | 30.94 | 15.97 | 15.59 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 27.76 | 24.14 | 24.11 |
| EPS (TTM) % | 37.08 | 33.10 | 25.73 |
| Dividend % | 23.00 | 20.67 | -- |
Note: Units in Millions of US Dollars
Performance for Hubei Jumpcan Pharmaceutical Co Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 9.28% |
| # of Holders: | 85 |
| Total Shares Held: | 75,648,857 |
| 3 Mo. Net Change: | 69,993 |
| # New Positions: | 2 |
| # Closed Positions: | 0 |
| # Increased Positions: | 10 |
| # Reduced Positions: | 9 |
| # Net Buyers: | 1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.